SYNERGETICS USA INC 4
4 · SYNERGETICS USA INC · Filed Oct 15, 2015
Insider Transaction Report
Form 4
Blankemeyer Robert H
Director
Transactions
- Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 totalExercise: $3.46Exp: 2023-12-13→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 totalExercise: $3.70Exp: 2024-12-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated as of September 1, 2015, by and among Valeant Pharmaceuticals International, Blue Subsidiary Corp. and Synergetics USA, Inc. (the "Merger Agreement"), on October 15, 2015, each option outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) was canceled in exchange for (i) a cash payment equal to the product of (A) the number of shares underlying the option and (B) the difference between $6.50, the cash consideration offered pursuant to the Merger Agreement, and the exercise price of the option; and (ii) one non-transferable contractual contingent value right per share underlying the option, which represents the right to receive up to two contingent payments, if any, of up to $1.00 in the aggregate, net to the holder in cash, upon the achievement of certain specified milestones within an agreed upon time period (less any applicable withholding taxes and without interest).